Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasin, D.
Right arrow Articles by Katz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasin, D.
Right arrow Articles by Katz, H.
Related Collections
Right arrow Somatoform
Right arrow Substance Abuse
Psychosomatic Medicine 69:870-875 (2007)
© 2007 American Psychosomatic Society


SOMATIC PRESENTATIONS: EPIDEMIOLOGY

Somatoform and Substance Use Disorders

Deborah Hasin, PhD and Hila Katz, BA

From the New York State Psychiatric Institute (D.H., H.K.), New York, New York; Department of Epidemiology (D.H.), Mailman School of Public Health, Columbia University, New York, New York; and the Department of Psychiatry (D.H.), College of Physicians and Surgeons, Columbia University, New York, New York.

Address correspondence and reprint requests to Deborah Hasin, Columbia University/New York State Psychiatric Institute, 1051 Riverside Drive, Box 123, New York, NY 10032. E-mail: dsh2{at}columbia.edu

ABSTRACT

Objective: To review the potential for diagnostic difficulties and overlap in a number of symptoms of somatoform disorders and symptoms of withdrawal from alcohol and drugs, and to review epidemiologic, family, and clinical studies addressing comorbidity between somatoform and substance use disorders. The comorbidity between somatoform disorders and substance use disorders has rarely been studied.

Methods: Symptoms of somatoform disorders and substance withdrawal were compared. A PubMed-based literature review was conducted.

Results: Somatoform and withdrawal symptoms overlap considerably. Few studies, however, have addressed comorbidity between somatoform and substance use disorders. Although results are inconsistent, a number of studies suggest that an association exists.

Conclusion: More research on this type of comorbidity is warranted because the associations may be stronger than generally assumed. Such research should address methodological problems to produce studies with clearer findings.

Key Words: somatoform • substance • abuse • dependence • somatization

Abbreviations: ECA = Epidemiologic Catchment Area; USD = undifferentiated somatoform disorder; SSI = Somatic Symptom Index; SSI4,6 = Somatic Symptom Index, 4 symptoms (men) and 6 symptoms (women).




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
J. E. Dimsdale, V. Patel, Y. Xin, and A. Kleinman
Somatic Presentations A Challenge for DSM-V
Psychosom Med, November 1, 2007; 69(9): 829 - 829.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Psychosomatic Society